BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 11688461)

  • 21. Large B-cell lymphoma with Hodgkin's features.
    García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational analysis of the 5' noncoding region of the bcl-6 gene in primary gastric lymphomas.
    Go JH; Yang WI; Ree HJ
    Mod Pathol; 2001 May; 14(5):410-4. PubMed ID: 11353050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation.
    Dunn-Walters DK; Boursier L; Spencer J; Isaacson PG
    Hum Pathol; 1998 Jun; 29(6):585-93. PubMed ID: 9635678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micronodular T-cell/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis.
    Dogan A; Burke JS; Goteri G; Stitson RN; Wotherspoon AC; Isaacson PG
    Am J Surg Pathol; 2003 Jul; 27(7):903-11. PubMed ID: 12826882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph node involvement by splenic marginal zone lymphoma: morphological and immunohistochemical features.
    Mollejo M; Lloret E; Menárguez J; Piris MA; Isaacson PG
    Am J Surg Pathol; 1997 Jul; 21(7):772-80. PubMed ID: 9236833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal follicular features in tonsillar diffuse large B-cell lymphomas: follicular lymphoma with diffuse areas or follicular colonization.
    Ree HJ; Kikuchi M; Lee SS; Ohshima K; Yang WI; Ko YH; Cho EY; Rhee JC
    Hum Pathol; 2002 Jul; 33(7):732-40. PubMed ID: 12196925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
    Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
    Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
    Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?
    Bosga-Bouwer AG; van den Berg A; Haralambieva E; de Jong D; Boonstra R; Kluin P; van den Berg E; Poppema S
    Hum Pathol; 2006 May; 37(5):528-33. PubMed ID: 16647949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.
    Trøen G; Nygaard V; Jenssen TK; Ikonomou IM; Tierens A; Matutes E; Gruszka-Westwood A; Catovsky D; Myklebost O; Lauritzsen G; Hovig E; Delabie J
    J Mol Diagn; 2004 Nov; 6(4):297-307. PubMed ID: 15507668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of cyclin D1 protein expression in splenic marginal zone lymphoma.
    Savilo E; Campo E; Mollejo M; Pinyol M; Piris MA; Zukerberg LR; Yang WI; Koelliker DD; Nguyen PL; Harris NL
    Mod Pathol; 1998 Jul; 11(7):601-6. PubMed ID: 9688179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma.
    Martinez-Climent JA; Sanchez-Izquierdo D; Sarsotti E; Blesa D; Benet I; Climent J; Vizcarra E; Marugan I; Terol MJ; Sole F; Cigudosad JC; Siebert R; Dyer MJ; García-Conde J
    Leuk Lymphoma; 2003 Mar; 44(3):459-64. PubMed ID: 12688315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease.
    Martinez D; Navarro A; Martinez-Trillos A; Molina-Urra R; Gonzalez-Farre B; Salaverria I; Nadeu F; Enjuanes A; Clot G; Costa D; Carrio A; Villamor N; Colomer D; Martinez A; Bens S; Siebert R; Wotherspoon A; Beà S; Matutes E; Campo E
    Am J Surg Pathol; 2016 Feb; 40(2):192-201. PubMed ID: 26426381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Splenic marginal zone lymphoma.
    Oscier D; Owen R; Johnson S
    Blood Rev; 2005 Jan; 19(1):39-51. PubMed ID: 15572216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
    Dogan A; Bagdi E; Munson P; Isaacson PG
    Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
    Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
    Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splenic marginal zone lymphoma.
    Dogan A; Isaacson PG
    Semin Diagn Pathol; 2003 May; 20(2):121-7. PubMed ID: 12945935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms: comparison with lymphomas associated with BCL2 rearrangement.
    Muramatsu M; Akasaka T; Kadowaki N; Ohno H; Yamabe H; Edamura S; Dor S; Mori T; Okuma M; Fukuhara S
    Br J Haematol; 1996 Jun; 93(4):911-20. PubMed ID: 8703825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
    Møller MB; Nielsen O; Pedersen NT
    Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.